DZ587A1 - 4-Aminoalkyl-2(3H) inolones. - Google Patents

4-Aminoalkyl-2(3H) inolones.

Info

Publication number
DZ587A1
DZ587A1 DZ847014A DZ847014A DZ587A1 DZ 587 A1 DZ587 A1 DZ 587A1 DZ 847014 A DZ847014 A DZ 847014A DZ 847014 A DZ847014 A DZ 847014A DZ 587 A1 DZ587 A1 DZ 587A1
Authority
DZ
Algeria
Prior art keywords
inolones
aminoalkyl
Prior art date
Application number
DZ847014A
Other languages
English (en)
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23776840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ587(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of DZ587A1 publication Critical patent/DZ587A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
DZ847014A 1982-12-07 1984-12-07 4-Aminoalkyl-2(3H) inolones. DZ587A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/447,564 US4452808A (en) 1982-12-07 1982-12-07 4-Aminoalkyl-2(3H)-indolones

Publications (1)

Publication Number Publication Date
DZ587A1 true DZ587A1 (fr) 2004-09-13

Family

ID=23776840

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ847014A DZ587A1 (fr) 1982-12-07 1984-12-07 4-Aminoalkyl-2(3H) inolones.

Country Status (27)

Country Link
US (1) US4452808A (fr)
EP (1) EP0113964B1 (fr)
JP (1) JPS59112964A (fr)
KR (1) KR910001042B1 (fr)
AU (1) AU560170B2 (fr)
BR (1) BR1100036A (fr)
CA (1) CA1208650A (fr)
CY (1) CY1497A (fr)
CZ (1) CZ398191A3 (fr)
DE (1) DE3367090D1 (fr)
DK (1) DK156514C (fr)
DZ (1) DZ587A1 (fr)
EG (1) EG16556A (fr)
ES (2) ES8600239A1 (fr)
FI (1) FI77849C (fr)
GR (1) GR79121B (fr)
HK (1) HK82089A (fr)
IE (1) IE56347B1 (fr)
IL (1) IL70311A (fr)
LU (1) LU90097I2 (fr)
NL (1) NL970005I2 (fr)
NO (2) NO160135C (fr)
NZ (1) NZ206344A (fr)
PH (1) PH22067A (fr)
PT (1) PT77739B (fr)
ZA (1) ZA839094B (fr)
ZW (1) ZW25883A1 (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8621040D0 (en) * 1986-08-30 1986-10-08 Smith Kline French Lab Process
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
CN1234024A (zh) * 1996-08-27 1999-11-03 美国家用产品公司 4－氨基乙氧基吲哚衍生物
EP1073636A1 (fr) * 1998-04-13 2001-02-07 American Home Products Corporation 4-amino-(ethylamino)-oxindoles utilises comme agonistes des autorecepteurs de la dopamine
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
PT1545546E (pt) * 2002-09-13 2007-07-02 Motac Neuroscience Ltd Tratamento da discinesia com 2, 3-benzodiazepinas
CN100502856C (zh) * 2002-09-17 2009-06-24 默塔克神经科学有限公司 运动障碍的治疗
ES2237307B1 (es) 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (fr) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Nouvelles formes cristallines d'hydrochlorure de 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (fr) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Hydrochlorure de 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone sensiblement pur
WO2005080333A1 (fr) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Processus de purification de ropinirole
PT1751106E (pt) * 2004-05-11 2009-02-10 Egis Gyogyszergyar Nyrt Derivados de piperazina de alquil-oxindoles
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法
WO2007010557A2 (fr) * 2005-07-22 2007-01-25 Ind-Swift Laboratorie Limted Methode de preparation de ropinirole tres pur
CA2645599A1 (fr) 2006-03-29 2007-10-04 Alembic Limited Procede de purification du chlorhydrate de ropinirole
PT2010184E (pt) * 2006-04-06 2013-04-03 Nupathe Inc Implantes para o tratamento dos estados associados à dopamina
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN100457732C (zh) * 2006-05-25 2009-02-04 药源药物化学（上海）有限公司 罗匹尼罗的制备方法
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
WO2008001204A2 (fr) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Compositions transdermiques de pramipexole présentant des propriétés de perméation améliorées
ATE535243T1 (de) * 2007-05-11 2011-12-15 Santen Pharmaceutical Co Ltd Prophylaktisches oder therapeutisches mittel für posteriore augenerkrankung mit selektivem nicht- ergot-d2-rezeptoragonist als wirkstoff
US20090076124A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched ropinirole
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (fr) * 2008-09-01 2010-03-04 Lupin Limited Nouvelles compositions de ropinirole à libération contrôlée
WO2010035245A2 (fr) 2008-09-29 2010-04-01 Wockhardt Research Centre Forme posologique à libération prolongée de ropinirole
WO2010060070A2 (fr) * 2008-11-24 2010-05-27 Auspex Pharmaceuticals, Inc. Modulateurs à base d'indolinone du récepteur de la dopamine
KR101709361B1 (ko) 2009-05-21 2017-02-22 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수 제제
AU2009356855A1 (en) * 2009-12-16 2012-08-09 Pharmathen S.A. Process for the preparation of Ropinirole and salts thereof
CN108186611A (zh) 2010-04-30 2018-06-22 帝国制药美国公司 丙炔基氨基茚满透皮组合物
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
JP5906302B2 (ja) 2011-03-24 2016-04-20 テイコク ファーマ ユーエスエー インコーポレーテッド 作用剤層および作用剤変換層を含む経皮組成物
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
WO2014070622A1 (fr) 2012-11-02 2014-05-08 Teikoku Pharma Usa, Inc. Compositions transdermiques de propynylaminoindane
WO2014092006A1 (fr) 2012-12-10 2014-06-19 キッセイ薬品工業株式会社 Nouveau dérivé d'octahydropyridoquinazoline, composition pharmaceutique le contenant, et utilisations pour ledit dérivé et ladite composition
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
EP3640240B1 (fr) 2017-06-16 2020-12-09 Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. Procédé de purification de chlorhydrate de ropinirole
CN115466209A (zh) * 2022-09-29 2022-12-13 南通大学 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA895875A (en) * 1972-03-21 Bourdais Jacques Mercapto indole derivatives
US3573310A (en) * 1967-09-28 1971-03-30 Miles Lab 1-substituted derivatives of 2-indolinone
JPS5825673B2 (ja) * 1976-03-31 1983-05-28 大塚製薬株式会社 オキシインド−ル誘導体
JPS5840539B2 (ja) * 1976-03-31 1983-09-06 大塚製薬株式会社 α−置換アミノアルカノイルオキシインド−ル誘導体
JPS5919537B2 (ja) * 1976-08-02 1984-05-07 大塚製薬株式会社 オキシインド−ル誘導体
US4317944A (en) * 1980-08-15 1982-03-02 General Electric Company Preparation of 2,2-bis(4-hydroxyphenyl) propane
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
DK156514C (da) 1990-03-12
ZA839094B (en) 1985-02-27
EP0113964A1 (fr) 1984-07-25
JPS59112964A (ja) 1984-06-29
CZ398191A3 (en) 1993-02-17
LU90097I2 (fr) 1997-07-16
AU560170B2 (en) 1987-04-02
US4452808A (en) 1984-06-05
IL70311A0 (en) 1984-02-29
FI834421A (fi) 1984-06-08
ZW25883A1 (en) 1984-04-18
IE56347B1 (en) 1991-07-03
NO160135C (no) 1989-03-15
JPH0150703B2 (fr) 1989-10-31
PH22067A (en) 1988-05-20
DK562183A (da) 1984-06-08
KR910001042B1 (ko) 1991-02-21
ES527827A0 (es) 1985-10-01
NL970005I2 (nl) 1997-10-01
PT77739B (en) 1986-03-27
NO1999011I1 (no) 1999-06-18
PT77739A (en) 1983-12-01
FI834421A0 (fi) 1983-12-02
AU2158583A (en) 1984-06-14
NZ206344A (en) 1987-03-31
NO160135B (no) 1988-12-05
EG16556A (en) 1989-01-30
DK562183D0 (da) 1983-12-06
ES8600239A1 (es) 1985-10-01
NO834485L (no) 1984-06-08
IE832866L (en) 1984-06-07
EP0113964B1 (fr) 1986-10-22
BR1100036A (pt) 2000-01-11
CY1497A (en) 1990-02-16
GR79121B (fr) 1984-10-02
NL970005I1 (nl) 1997-04-01
DE3367090D1 (de) 1986-11-27
ES8604143A1 (es) 1986-01-16
DK156514B (da) 1989-09-04
ES543593A0 (es) 1986-01-16
FI77849C (fi) 1989-05-10
KR840006963A (ko) 1984-12-04
FI77849B (fi) 1989-01-31
IL70311A (en) 1986-11-30
HK82089A (en) 1989-10-20
CA1208650A (fr) 1986-07-29

Similar Documents

Publication Publication Date Title
DZ587A1 (fr) 4-Aminoalkyl-2(3H) inolones.
FI78601B (fi) Engaongsbloeja.
FI78611B (fi) Uppbevaringspaose.
FI73534B (fi) Bandkassett.
FI73505B (fi) Faestelement.
FI842543A (fi) Transportlaoda.
NO831596L (no) Roerlednings-stoette.
FI77050B (fi) Gelatinkomposition foer sprutgjutning.
FI78606B (fi) Saekerhetssaete.
DE3381054D1 (de) Immunoessay.
FI834178A (fi) Avsaendar- och mottagarantenner.
FI834433A (fi) Svaenghjulskraftoeverfoering.
FI73520B (fi) Maolanordning.
FI842060A0 (fi) Foerstaerkarkoppling.
FI834725A (fi) Tryckmediepaoverkad gripanordning.
DE3382498D1 (de) Konservenbuechse.
ES272075Y (es) Corretilla.
FI841618A0 (fi) Foer rostbehandling avsedda kompositioner.
FI841575A (fi) Tangentmekanism.
NO163198C (no) Foringsroer-innrettingsverktoey.
FI834357A (fi) Dragfordon.
FI843194A (fi) Verkningsanordning.
MX9203742A (es) 4-aminoalquil-2(3h)-indolonas.
FI73929B (fi) Foerflyttbar lasttransportoer.
NO820446L (no) Vaeskedoseringsanordning.